Sheila Mikhail
Company: AskBio
Job title: Co-Founder & Former Chief Executive Officer
Bio:
Sheila has started and successfully exited several gene therapy companies, including Chatham Therapeutics (sold to Baxter 2014), Bamboo Therapeutics (sold to Pfizer 2016), and AskBio (sold to Bayer 2020). She deployed several creative funding strategies and only raised institutional capital once in 2019.
Seminars:
Making the Case for Gene Therapy in a Tough Market 3:15 pm
Alternative funding strategies for a tough financing market Unusual business models for ultra-rare indications and emerging economies Making the commercial proposition for gene therapies more valuableRead more
day: Day One PM
Maintaining investment incentives for rare disease programs 9:00 am
Topics to be Discussed: How to attract investment into a rare gene therapy program Demonstrating value proposition to potential investors Considerations for diseases with other treatment options Outlining required capabilities and infrastructure for scaling up a biotechRead more
day: decision makers day - track a